This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: The Innovations of Fengchun Chen
Introduction
Fengchun Chen is a notable inventor based in Chengdu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for medical use. His work focuses on addressing critical health issues through novel chemical formulations.
Latest Patents
Fengchun Chen holds 1 patent for his invention titled "Solid form of azetidine derivative and preparation method therefor and use thereof." This patent relates to a solid form of a compound designed to treat Janus kinase (JAK) related diseases, including inflammatory diseases, autoimmune diseases, and cancers. The invention encompasses a method for preparing the solid form, a pharmaceutical composition that includes the solid form, and its applications in medical treatments.
Career Highlights
Fengchun Chen is currently associated with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. His role in the company allows him to leverage his expertise in biopharmaceuticals to develop innovative solutions for complex health challenges. His contributions have been instrumental in advancing the company's research and development efforts.
Collaborations
Fengchun Chen collaborates with talented professionals in his field, including Ping Zhang and Lichun Wang. These collaborations enhance the research environment and foster innovation within the company.
Conclusion
Fengchun Chen's work exemplifies the spirit of innovation in the pharmaceutical industry. His patent for a solid form of azetidine derivative showcases his commitment to developing effective treatments for serious health conditions. Through his career at Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., he continues to make impactful contributions to medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile